Novobiocin, a Newly Found TRPV1 Inhibitor, Attenuates the Expression of TRPV1 in Rat Intestine and Intestinal Epithelial Cell Line IEC-6
Background and Purpose: Novobiocin (NOVO), an ABC transporter inhibitor, decreases intestinal wall permeability of capsaicin (CAP), an ABC transporter substrate. However, the mechanism of this effect is not consistent with the action of NOVO as an ABC transporter inhibitor. We previously found that...
Main Authors: | Qianying Liang, Xueli Lv, Qing Cai, Yun Cai, Boxin Zhao, Guofeng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01171/full |
Similar Items
-
TRPV1: A Target for Rational Drug Design
by: Vincenzo Carnevale, et al.
Published: (2016-08-01) -
Identification and Quantification of Transient Receptor Potential Vanilloid 1 (TRPV1) in Equine Articular Tissue
by: Anne Frank Gallagher vom Braucke, et al.
Published: (2020-03-01) -
Interference of TRPV1 function altered the susceptibility of PTZ-induced seizures
by: Yun-Fang eJia, et al.
Published: (2015-02-01) -
Structure, function, and mechanism of action of the
vanilloid TRPV1 receptor
by: Paweł Siudem, et al.
Published: (2020-11-01) -
Sensitization and translocation of TRPV1 by insulin and IGF-I
by: Pauza Mary E, et al.
Published: (2005-04-01)